Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnolia kobus flowering top is a botanical extract derived from the flowers of the *Magnolia kobus* tree. While not an FDA-approved pharmaceutical drug, it is utilized as an active ingredient in over-the-counter (OTC) topical cosmetic products, such as "Magnolia Serum," primarily for skin whitening and brightening. The extract contains bioactive compounds including phytosterols (campesterol and stigmasterol) and phenylpropanoids, which contribute to its reported antioxidant and antibacterial properties. It has been marketed by companies like Grace & Truth Co., Ltd. and Salon de Savon, though the FDA has noted that these products lack established safety and efficacy data for their labeled claims.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Magnolia kobus flowering top.